Literature DB >> 26260113

The timed up and go test for lumbar degenerative disc disease.

Oliver P Gautschi1, Marco V Corniola2, Holger Joswig3, Nicolas R Smoll4, Ivan Chau3, Dario Jucker3, Martin N Stienen5.   

Abstract

We report on the use and performance of an objective measure of functional impairment, the timed up and go (TUG) test, in clinical practice for patients with lumbar degenerative disc disease (DDD). We illustrate nine representative patients with lumbar DDD, who were selected from an ongoing prospective study, to report our clinical experience with the TUG test. In addition, a preliminary sample of 30 non-selected consecutive patients is presented. The following parameters were assessed preoperatively, and 3 days and 6 weeks postoperatively: back and leg pain using the visual analogue scale (VAS); functional impairment using the Oswestry disability index (ODI) and Roland-Morris disability index (RMDI); health-related quality of life using the EuroQol 5D (EQ5D) and Short-Form 12 (SF-12). The TUG test results improved by 2.6 and 5.4s after 3 days and 6 weeks compared to the baseline assessment. The mean VAS for back and leg pain decreased by 2.3 and 5.3, respectively, after 3 days, and by 2.7 and 4.6 after 6 weeks. The mean RMDI and ODI decreased by 3.4 and 23.3, respectively, after 3 days, and by 7.0 and 28.0 after 6 weeks. The mean EQ5D increased by 0.38 after 3 days and 0.358 after 6 weeks. The mean SF-12 mental component scale decreased by 0.2 after 3 days and increased by 5.6 after 6 weeks, whereas the mean SF-12 physical component scale increased by 6.4 after 3 days and by 9.8 after 6 weeks. The TUG test proved to be a useful, easy to use tool that could add a new, objective dimension to the armamentarium of clinical tests for the diagnosis and management of DDD. From our preliminary experience, we conclude that the TUG test accurately reflects a patient's objective functional impairment before and after surgery.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health-related quality of life; Lumbar degenerative disc disease; Objective functional impairment; Subjective outcome measures; Timed up and go test

Mesh:

Year:  2015        PMID: 26260113     DOI: 10.1016/j.jocn.2015.04.018

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

Review 1.  Realignment surgery in adult spinal deformity : Prevalence and risk factors for proximal junctional kyphosis.

Authors:  B G Diebo; N V Shah; S G Stroud; C B Paulino; F J Schwab; V Lafage
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

2.  Kinesiophobia, Pain, Muscle Functions, and Functional Performances among Older Persons with Low Back Pain.

Authors:  Nor Azizah Ishak; Zarina Zahari; Maria Justine
Journal:  Pain Res Treat       Date:  2017-05-29

3.  Lower Extremity Motor Deficits Are Underappreciated in Patient-Reported Outcome Measures: Added Value of Objective Outcome Measures.

Authors:  Martin Nikolaus Stienen; Nicolai Maldaner; Marketa Sosnova; Holger Joswig; Marco Vincenzo Corniola; Luca Regli; Gerhard Hildebrandt; Karl Schaller; Oliver Pascal Gautschi
Journal:  Neurospine       Date:  2020-01-26

4.  Deep Learning-Based Subtask Segmentation of Timed Up-and-Go Test Using RGB-D Cameras.

Authors:  Yoonjeong Choi; Yoosung Bae; Baekdong Cha; Jeha Ryu
Journal:  Sensors (Basel)       Date:  2022-08-23       Impact factor: 3.847

5.  The potential effect of type 2 diabetes mellitus on lumbar disc degeneration: a retrospective single-center study.

Authors:  Xiaoming Liu; Fumin Pan; Zhaoyu Ba; Shanjin Wang; Desheng Wu
Journal:  J Orthop Surg Res       Date:  2018-03-14       Impact factor: 2.359

6.  SIZE study: study protocol of a multicentre, randomised controlled trial to compare the effectiveness of an interarcuair decompression versus extended decompression in patients with intermittent neurogenic claudication caused by lumbar spinal stenosis.

Authors:  Jamie Arjun Sharma; Pravesh S Gadjradj; Wilco C Peul; Maurits W van Tulder; Wouter A Moojen; Biswadjiet S Harhangi
Journal:  BMJ Open       Date:  2020-10-06       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.